VALN VALN
Company Profile ↓Company Overview
VALN (VALN) is a publicly traded company listed on with a market capitalization of $907.61M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $174.66M (+3.0% YoY); net profit $-115.19M.
- Trailing 12 Months Year-on-year growth — revenue +3.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -21.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -21.52% |
| 1 Year: | 3.00% |
Stock Price Performance
| 1 Year: | -27.54% |
| 6 Months: | -42.34% |
| 3 Months: | -1.13% |
| 1 Month: | -0.57% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)54.70 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -21.5% CAGR over 5 years.
- Trading 57.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 49.23M | 48.33M | 29.41M | 47.69M | 30.90M |
| Cost of Revenue | - | 23.04M | 24.12M | 23.91M | 36.07M | 26.18M |
| Gross Profit | - | 26.19M | 24.21M | 5.50M | 11.62M | 4.72M |
| Operating Expenses | - | 32.15M | 34.85M | 42.85M | 39.30M | 28.42M |
| Operating Income | - | -5.96M | -10.64M | -37.35M | -27.68M | -23.70M |
| EBITDA | - | -1.78M | -6.20M | -37.80M | -26.44M | -26.16M |
| Interest Expense | - | 5.98M | 5.61M | 5.67M | 24.64M | 5.09M |
| Pretax Income | - | -7.76M | -11.81M | -43.47M | -51.08M | -31.25M |
| Tax Provision | - | 1.47M | -223.00K | 882.00K | -1.06M | 824.00K |
| Net Income | - | -9.23M | -11.59M | -44.35M | -50.02M | -32.07M |
| Diluted EPS | - | -0.12 | - | - | - | -0.36 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 361.30M | 153.71M | 169.58M | 174.66M |
| Cost of Revenue | - | 324.44M | 100.88M | 98.54M | 107.14M |
| Gross Profit | - | 36.86M | 52.84M | 71.04M | 67.52M |
| Operating Expenses | - | 150.31M | 134.95M | 148.81M | 149.15M |
| Operating Income | - | -113.44M | -82.11M | -77.77M | -81.63M |
| EBITDA | - | -104.72M | -57.72M | 32.08M | -50.47M |
| Interest Expense | - | 19.05M | 23.32M | 23.98M | 41.90M |
| Pretax Income | - | -144.81M | -98.63M | -11.49M | -114.12M |
| Tax Provision | - | -1.54M | 2.80M | 761.00K | 1.07M |
| Net Income | - | -143.28M | -101.43M | -12.25M | -115.19M |
| Diluted EPS | - | -2.48 | -1.46 | -0.16 | -1.36 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 621.34M | 460.06M | 500.03M | 398.84M |
| Current Assets | - | 424.66M | 262.82M | 299.01M | 222.54M |
| Cash & Equivalents | - | 286.53M | 126.08M | 168.27M | 109.65M |
| Inventory | - | 35.10M | 44.47M | 53.66M | 50.23M |
| Receivables | - | 23.91M | 41.65M | 35.13M | 27.73M |
| Total Liabilities | - | 401.55M | 331.81M | 318.78M | 292.67M |
| Current Liabilities | - | 277.39M | 158.86M | 114.58M | 93.33M |
| Long Term Debt | - | 87.23M | 132.77M | 166.52M | 161.26M |
| Total Debt | - | 152.38M | 208.82M | 216.31M | 207.25M |
| Total Equity | - | 219.80M | 128.25M | 181.25M | 106.17M |
| Shares Outstanding | - | 138.49M | 138.91M | 162.52M | 173.54M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -245.34M | -202.74M | -67.22M | -52.89M |
| Investing Cash Flow | - | -29.05M | -20.59M | 76.92M | -1.71M |
| Financing Cash Flow | - | 215.12M | 63.08M | 30.68M | -621.00K |
| Capital Expenditure | - | -29.32M | -14.31M | -16.44M | -4.48M |
| Free Cash Flow | - | -274.67M | -217.06M | -83.66M | -57.38M |
| Net Change in Cash | - | -59.28M | -160.25M | 40.38M | -55.22M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 10.2% | 34.4% | 41.9% | 38.7% |
| Operating Margin % | - | -31.4% | -53.4% | -45.9% | -46.7% |
| Net Margin % | - | -39.7% | -66.0% | -7.2% | -66.0% |
| ROE % | - | -65.2% | -79.1% | -6.8% | -108.5% |
| ROCE % | - | -33.0% | -27.3% | -20.2% | -26.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VALN
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNWV9QaFZIOTlEd2ZWS0oxb29hdWtCcWpmd0ZCSFpfTUNzc1pzU2o5R09VUk5fSnhUT1dDeHo3NER6c0lLbmpJUFVBc243X29jS0tOU0Rad2ZCSEtNLV9BUjgwYlY3ZUI4Mm9iZ1hHMlNQa0NDN2NsRU9TNUxBZ2JQd2dvcVN4WkxNX054al…
Valneva SE (Nasdaq: VALN) sets Aug. 13 webcast on 2026 first-half results - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcFBDcXYxWFA5ZXl6dHFzWURHZnZkdUF2elB1ZXNiUXlzRWpuOVZCNHNnRmlDMkNUY0tqNmxGZ1Z5eGVzbzRKeEQxbXlTakVRYWY1OEQ2a1JNaDI2YTlEUlJEZWo0NjlvNThYRy0wLUFMSzJCczhaeG1PYTRJcVBCNDVPaXZKMnFEUmFiMG…
Jefferies reiterates Valneva stock Buy rating after Lyme trial data - Investing.com
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNUXVTMzR2TVBqZlpwY2dWMU5iSkg3eTIxMWJ2ZmwwMzNQNjVGUVd1QVdVVVdEZVVwSlBfSnNtdkpmdVVRSVJzd184WHNnbTJWeTRrSGk0TF9YSVMta3pjdUJKTkZFcEJIdjdZV1pvcnBPWnZzVms3aFpWQzVTdXZUZGFDRzh6X3BPOUZxOG…
Valneva SE (VALN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE56YjRmZGhEampEcklXWmRLWVh5Q3VIaFlrYl8ybTNVeVhuQ0c5YThHRzZTcnNOUFhycl9BMVh3aHhJRmhCZk9pZDRoQ1p3SEtzYnB2RE5qTmdKTXpwOVpBVGs5c00yRTJZSHZEYk93?oc=5" target="_blank">Valneva SE (VALN) R…
Valneva (VALN) Shares Edge Lower, Stabilizing Near Key Support Levels - Fair Value Gap - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOVi15eUN0SHVhLUdDbHNuREYwZnU0b2RpamRtMzVxbEc5LVpzRFBTWVVBa2tqMGJsdUt0RUExV0FkUVRrbFl6NzlDMktWc3BlLXZ0RXUyczJmM2QxM1RGU0dDM2pmNi04X256TkYwcUdqOGRUM3M4TUNONGZoY2J1ZV9wQUhHTVhUcDV0ZH…
How Valneva Se (VALN) Affects Rotational Strategy Timing - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQb1ZBa0VnZkJFN29sTFRBejJlMjhhaTRrN2haVElTTGpadEVJdk1fOXRnUmItbkJoZDBnMWZoRUZGWVozcXAzNWpmS2tGZVRsMExEZko0SmdHZkNCdVp1dXV1R28wMFMyeHRKQUl0X1lSSmNEUkktV0xkSlVFZHJ0YkZDVEg0dTZEb1NEYW…
VALN — Frequently Asked Questions
What is the current share price of VALN?
As of 2026-08-05 17:25 PDT, VALN trades at $5.23 on NASDAQ/NYSE. Its 52-week range is $4.78 to $12.20.
What is the market capitalisation of VALN?
VALN has a market capitalisation of $907.61M on NASDAQ/NYSE.
What is the P/E ratio of VALN?
VALN trades at a trailing price-to-earnings (P/E) ratio of -3.85. Its price-to-book (P/B) ratio is 8.55.
What is the return on equity (ROE) of VALN?
VALN has a return on equity (ROE) of -108.50%. Its return on capital employed (ROCE) is -26.72%.
Is VALN a good stock to buy?
This page provides a data-driven analysis of VALN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.